E645-1432 Screening compound: 3-[8-methyl-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[2-(2-thienyl)ethyl]propanamide

E645-1432 Screening compound: 3-[8-methyl-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[2-(2-thienyl)ethyl]propanamide
E645-1432 Screening compound: 3-[8-methyl-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[2-(2-thienyl)ethyl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E645-1432
3-[8-methyl-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[2-(2-thienyl)ethyl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E645-1432

Molecular Formula

C22H21N3O3S (C22 H21 N3 O3 S)

Compound Name

3-[8-methyl-5-oxopyrido[2,3-b][1,5]benzoxazepin-6(5H)-yl]-N~1~-[2-(2-thienyl)ethyl]propanamide

IUPAC name

3-{13-methyl-9-oxo-2-oxa-410-diazatricyclo[9.4.0.0^{38}]pentadeca-1(11)3(8)461214-hexaen-10-yl}-N-[2-(thiophen-2-yl)ethyl]propanamide

SMILES

Cc(cc1)cc(N2CCC(NCCc3cccs3)=O)c1Oc(nccc1)c1C2=O

InChI

InChI=1S/C22H21N3O3S/c1-15-6-7-19-18(14-15)25(22(27)17-5-2-10-24-21(17)28-19)12-9-20(26)23-11-8-16-4-3-13-29-16/h2-7,10,13-14H,8-9,11-12H2,1H3,(H,23,26)

InChI Key

MOMPLKXOHKEBAN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14907694

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

407.49

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.179

Distribution Coefficient, logD

3.179

Water Solubility, LogSw

-3.62

Polar Surface Area

57.842

Acid Dissociation Constant (pKa)

13.91

Base Dissociation Constant (pKb)

-0.41

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.70

E645-1432 in Drug Discovery

Included in Screening Libraries

Protein-Protein Interaction Library (218420 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Therapeutical areas:
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Kinases
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E645-1432 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E645-1432?
Check Price and Availability of E645-1432, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E645-1432 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E645-1432
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E645-1432
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E645-1432 available by request